MDLZ
36
2
STI
41
-3
IVZ
46
-2
EXR
33
-11
HRB
40
4
NFLX
65
-3
AXP
60
-2
URBN
68
-2
SPG
50
2
DVN
16
2
ESS
51
4
MTCH
55
-4
PCG
69
2
LMT
29
4
WAT
55
-2
TGNA
45
-2
UHS
51
3
PSX
32
3
MSFT
48
-3
MPC
36
3
MDLZ
36
2
STI
41
-3
IVZ
46
-2
EXR
33
-11
HRB
40
4
NFLX
65
-3
AXP
60
-2
URBN
68
-2
SPG
50
2
DVN
16
2
ESS
51
4
MTCH
55
-4
PCG
69
2
LMT
29
4
WAT
55
-2
TGNA
45
-2
UHS
51
3
PSX
32
3
MSFT
48
-3
MPC
36
3
Financhill
Back

Steris PLC 10K Form

Sell
42

STE
Steris PLC

Last Price:
$202.45
Seasonality Move:
2.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive STE News And Ratings

See the #1 stock for the next 7 days that we like better than STE

STE Financial Statistics

Sales & Book Value

Annual Sales: $5.1B
Cash Flow: $148.8M
Price / Cash Flow: 30.03
Annual Sales: $66.80
Price / Book: 3.08

Profitability

EPS (TTM): 4.38000
Net Income (TTM): $434.8M
Gross Margin: $2.2B
Return on Equity: 6.81%
Return on Assets: 4.02%

Steris PLC Earnings Forecast

Key Steris PLC Financial Ratios

  • The Gross Profit Margin over the past 34 years for STE is 43.17%.
  • The Selling, General & Administrative Expenses for STE have been equal to 24.37% of Gross Profit Margin.
  • The Research & Development expenses have been 2.02% of Revenue.
  • The Interest Expense is 38.16% of Operating Income.
  • The Net Earning history of STE is 7.36% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 20 years.

Steris PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: STE
CUSIP: G84720
Website: steris.com

Debt

Debt-to-Equity Ratio: 0.34
Current Ratio: 2.41
Quick Ratio: 1.36

Price-to-Earnings

Trailing P/E Ratio: 53.95
Forward P/E Ratio: 20.69

STE Technical Analysis vs Fundamental Analysis

Sell
42
Steris PLC (STE) is a Sell

Is Steris PLC a Buy or a Sell?

  • Steris PLC stock is rated a Sell
    The current Steris PLC [STE] share price is $205.56. The Score for STE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.